Cargando…
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
Introduction: Fifty years after the discovery of Δ(9)-tetrahydrocannabinol (THC) as the psychoactive component of Cannabis, we are assessing the possibility of translating this herb into clinical treatment of inflammatory bowel diseases (IBDs). Here, a discussion on the problems associated with a po...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388177/ https://www.ncbi.nlm.nih.gov/pubmed/28276820 http://dx.doi.org/10.1080/17474124.2017.1292851 |